New Evidence Solidifies Link Between Fosamax and Femur Fractures
Fosamax is intended for the purpose of treating and preventing osteoporosis—a condition in which the bones become thin and weak and break easily—in men and post-menopausal women. But unfortunately, Fosamax has been increasingly linked to incidents of femur fractures, as further indicated by not one, but three recent medical journal reports. Patients who use Fosamax for prolonged periods of time are shown to have a greater likelihood of developing unusual bone fractures. Even the Food and Drug Administration updated the warning label on Fosamax and similar bisphosphonate drugs, in order to alert the public about an elevated risk of atypical fractures of the thigh.
While the FDA has not gone so far as to declare a definitive link, the evidence is pretty overwhelming. In fact, a report in the American Society of Bone and Mineral research uncovered that more than 300 osteoporosis sufferers experienced a rare femur fracture, and of those patients, 94% were taking Fosamax or a similar a bisphosphonate drug.
Now a new report, entitled “”Seek and ye shall find – subtrochanteric stress fractures in patients on oral bisphosphonate therapy; an emerging problem,” adds further credence to the link, pointing out that “This fracture is often preceded by pain and distinctive radiographic changes, and associated with a characteristic fracture pattern.” The second new article, “Atypical subtrochanteric femoral shaft fractures: role for mechanics and bone quality,” goes into dramatic detail about problems found with such as Fosamax (alendronate), Actonel (risedronate), Boniva (ibandronate). According to the article:
These fractures have several atypical characteristics, including occurrence with minimal trauma; younger age than typical osteoporotic fractures; occurrence at cortical, rather than cancellous sites; early radiographic appearance similar to that of a stress fracture; transverse fracture pattern rather than the familiar spiral or transverse-oblique morphologies; initiation on the lateral cortex; and high risk of fracture on the contralateral side, at the same location as the initial fracture.
The third article is called “Spontaneous incomplete transverse subtrochanteric femoral fracture with cortical thickening possibly secondary to risedronate use: a case report,” from the Journal of Medical Case Reports, and draws many of the same conclusions. If you have taken the drug Fosamax or a similar bisphosponate, and have suffered from bone fracture, you may be entitled to monetary compensation.
The Law Offices of Nadrich & Cohen LLP has assisting victims of Fosamax side effects for years, and we work with patients in California and throughout the nation. We are contingency lawyers, which means that we only get paid if you receive a recovery. Call us today for a free consultation at 1-800-718-4658. Your case evaluation is always confidential, and we work aggressively to ensure that our clients receive the justice that they deserve. Call the Fosamax attorneys at Nadrich & Cohen today.